Sun Pharmaceutical Industries Q3 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,823.35
-1.35 (-0.07%)
-1.35 (-0.07%)Volume1.89 L
Updated: Fri 6 Sep, 2024 | 15:43:58
NSE
1,824.55-1.95 (-0.11%)
-1.95 (-0.11%)Volume1.70 M
Updated: Fri 6 Sep, 2024 | 15:56:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 12,380.70 | 12,192.41 | 1.54% | 11,240.97 | 10.14% |
| Selling/ General/ Admin Expenses Total | 2,363.32 | 2,364.36 | -0.04% | 2,037.07 | 16.02% |
| Depreciation/ Amortization | 622.14 | 632.82 | -1.69% | 659.95 | -5.73% |
| Other Operating Expenses Total | 3,928.17 | 3,827.49 | 2.63% | 3,393.38 | 15.76% |
| Total Operating Expense | 9,720.38 | 9,611.76 | 1.13% | 8,894.07 | 9.29% |
| Operating Income | 2,660.32 | 2,580.65 | 3.09% | 2,346.90 | 13.35% |
| Net Income Before Taxes | 3,000.35 | 2,790.88 | 7.51% | 2,471.47 | 21.40% |
| Net Income | 2,523.75 | 2,375.51 | 6.24% | 2,166.01 | 16.52% |
| Diluted Normalized EPS | 10.75 | 9.90 | 8.57% | 9.00 | 19.43% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Sept 9
4 min read07:00 AM IST - Markets
02“Baseless, misleading”: Wockhardt refutes allegations of rent payment by Carol Info to SEBI chief Madhabi Buch
5 min read7 Sep 2024 - Markets
03Dividend Stocks: Vedanta, Gujarat Gas, Harsha Engineering, among others to trade ex-dividend next week; Full list here
6 min read7 Sep 2024